doi: 10.1021/jm00241a013.
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone
- PMID: 168385
- DOI: 10.1021/jm00241a013
Item in Clipboard
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone
J Med Chem.
1975 Jul.
Abstract
The synthesis of 4'-epi-daunorubicin and of 4'-epi-adriamycin was performed by condensation of 2,3,6-trideoxy-3-trifluoroacetamido-4-O-trifluoroacetyl-alpha-L-arabino-hexopyranosyl chloride with daunomycinone or the protected adriamycinone derivative 17, respectively. Both the alpha and beta anomers were obtained and characterized. All new compounds are biologically active in cultured cells and the alpha anomers display noticeable activity in experimental tumors in mice. Interestingly, 4'-epi-adriamycin (4) appears nontoxic to cultured heart cells up to a concentration of 5 mug/ml.
Similar articles
-
Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines.J Med Chem. 1976 May;19(5):733-4. doi: 10.1021/jm00227a033. J Med Chem. 1976. PMID: 1271420 No abstract available.
-
New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.J Antibiot (Tokyo). 1985 Jul;38(7):856-67. doi: 10.7164/antibiotics.38.856. J Antibiot (Tokyo). 1985. PMID: 3861603
-
Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin.J Med Chem. 1974 Mar;17(3):335-7. doi: 10.1021/jm00249a017. J Med Chem. 1974. PMID: 4811230 No abstract available.
-
New daunorubicin analogs. 3-Amino-2,3,6-trideoxy-alpha- and beta-D-arabino- and 3,6-diamino-2,3,6-trideoxy- alpha-D-ribo-hexopyranosides of daunomycinone.J Antibiot (Tokyo). 1979 Mar;32(3):223-38. doi: 10.7164/antibiotics.32.223. J Antibiot (Tokyo). 1979. PMID: 457582
-
Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.Experientia. 1978 Oct 15;34(10):1255-7. doi: 10.1007/BF01981401. Experientia. 1978. PMID: 570116
Cited by
-
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.Cancer Chemother Pharmacol. 1988;21(3):221-8. doi: 10.1007/BF00262774. Cancer Chemother Pharmacol. 1988. PMID: 3162849
-
Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors.Cancer Chemother Pharmacol. 1986;16(2):176-7. doi: 10.1007/BF00256171. Cancer Chemother Pharmacol. 1986. PMID: 3456282
-
Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.Cancer Chemother Pharmacol. 1992;31 Suppl:S55-9. doi: 10.1007/BF00687106. Cancer Chemother Pharmacol. 1992. PMID: 1281046 Clinical Trial.
-
Anthracyclines--modern tumour-inhibiting agents.Folia Microbiol (Praha). 1978;23(2):152-61. doi: 10.1007/BF02915316. Folia Microbiol (Praha). 1978. PMID: 348587 Review. No abstract available.
-
Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.J Virol. 2019 Nov 13;93(23):e01411-19. doi: 10.1128/JVI.01411-19. Print 2019 Dec 1. J Virol. 2019. PMID: 31511390 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources